PCN69 - To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)

Journal article

Open access

Peer reviewed

M Rauf, R Dada, N Awad, M Safwat, A Narang and R Goyal

Value in health, Vol.20(9), pp.A424-A424

10/2017

Files and links (1)

url

https://doi.org/10.1016/j.jval.2017.08.152View

Published (Version of record) Open

1 Record Views

Title: PCN69 - To Determine The Financial Imapct of Introducing Sc Rituximab (MABTHERA) vs. Currently used iv rituximab (MABTHERA) on The Budgets of Different Hospitals Across The Kingdom of Saudi Arabia (KSA)
Creators - without role: M Rauf - King Faisal Specialist Hospital, Riyadh, Saudi Arabia
R Dada - King Faisal Specialist Hospital & Research Centre
N Awad - IQVIA
M Safwat - IQVIA
A Narang - QunitilesIMS, Gurugram, India
R Goyal - IQVIA
Publication Details: Value in health, Vol.20(9), pp.A424-A424
Publisher: Elsevier Inc
Identifiers: 9913742008331
Academic Unit: King Faisal University; Alfaisal University
Language: English
Resource Type: Journal article